AlTi Global’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

AlTi Global’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,071	Closed	-$255K	–	453
2025 Q2	$255K	Hold	3,071	–	–	0.01%	376
2025 Q1	$249K	Hold	3,071	–	–	0.01%	352
2024 Q4	$277K	Sell	3,071 -560	-15%	-$54.3K	0.01%	352
2024 Q3	$359K	Sell	3,631 -288	-7%	-$28.3K	0.01%	303
2024 Q2	$363K	Sell	3,919 -143	-4%	-$12.8K	0.01%	296
2024 Q1	$385K	Sell	4,062 -8	-0.2%	-$742	0.01%	284
2023 Q4	$363K	Buy	+4,070	New	+$302K	0.01%	272

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

AlTi Global's XBI Position: Q3 2025 in Review

AlTi Global sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 3,071 shares — an estimated $255K sold.

AlTi Global first reported a position in XBI in Q4 2023 and held it in 7 quarters. The position peaked at $385K in Q1 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

AlTi Global reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
AlTi Global sold 3,071 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $255K.
AlTi Global first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 7 quarters.
AlTi Global's State Street SPDR S&P Biotech ETF position peaked at $385K in Q1 2024.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on AlTi Global's 13F filing for Q3 2025, filed 6 Nov 2025.